REG - EKF Diagnostics Hldg - Executive Chair share purchase

EKF Diagnostics HoldingsAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251216:nRSP6381La&default-theme=true

RNS Number : 6381L  EKF Diagnostics Holdings PLC  16 December 2025

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Executive Chair share purchase

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics
business, announces that on Monday 15 December, Julain Baines, Executive
Chair, purchased a total of 85,000 ordinary shares of 1 pence each in the
Company ("Ordinary Shares") at a price of 23.0 pence per Ordinary Share.

 

Following this transaction, Julian Baines' total interest in the Company is
1,751,288 Ordinary Shares, representing approximately 0.40% of the total
voting rights over the Company's issued share capital.

 

The Notification of Dealing Form required in accordance with UK MAR is set out
below as is the Standard form for notification of major holdings received by
EKF today.

 

 EKF Diagnostics Holdings plc                              www.ekfdiagnostics.com (http://www.ekfdiagnostics.com)
 Julian Baines, Executive Chair                             Via Walbrook PR
 Gavin Jones, Chief Executive Officer
                                                           Tel: +44 (0)20 7496 3000
 Singer Capital Markets (Nominated Adviser & Broker)
 Phil Davies / Oliver Platts

 Walbrook PR Limited            Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com (mailto:ekf@walbrookpr.com)
 Paul McManus / Alice Woodings  Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

 

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com
(http://www.ekfdiagnostics.com) )

 

EKF is an AIM-listed global diagnostics business focussed on:

 

·    Point-of-Care analysers in the key areas of Hematology and Diabetes.

·    Life Sciences services provide specialist manufacture of enzymes and
custom products for use in diagnostic food and industrial applications.

 

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing
sites across the US and Germany, selling into over 120 countries world-wide.

 

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                          Julian Baines

 2    Reason for the notification

 a)   Position/status                                              Executive Chair

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         EKF Diagnostics Holdings plc

 b)   LEI                                                          213800DXTF3EAUK1AR05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 1 pence each

      Identification code                                          GB0031509804

 b)   Nature of the transaction                                    Purchase of Ordinary Shares

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     23p               85,000

 d)   Aggregated information

      - Aggregated volume                                          N/A single transaction

      - Price

 e)   Date of the transaction                                       15 December 2025

 f)   Place of the transaction                                     London Stock Exchange, AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUVVVRVOUUAAA



            Copyright 2019 Regulatory News Service, all rights reserved